Evidence map›Paper›PMID 34567124›Full record

ArticleInternational journal of microbiology2021

Maria Domenica Falciglia, Roberta Palladino, Barbara Maglione, Giulia Schiavo

Abstract read
In one paragraph

Article in International journal of microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Efficacy of a Novel RigenaseMedicina (Kaunas, Lithuania) · 2023
    Observational
  4. Journal of clinical medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maria Domenica FalcigliaFarmaceutici Damor S.p.a, Via E. Scaglione 27, Napoli, Italy.
Roberta PalladinoFarmaceutici Damor S.p.a, Via E. Scaglione 27, Napoli, Italy.
Barbara MaglioneFarmaceutici Damor S.p.a, Via E. Scaglione 27, Napoli, Italy.
Giulia SchiavoFarmaceutici Damor S.p.a, Via E. Scaglione 27, Napoli, Italy.ORCID https://orcid.org/0000-0002-0579-4845

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wound contaminants are the main cause of healing delay and infection in both chronic and acute wounds; for this reason, the microbial infection management in wound healing is one of the most important components for an effective standard of care. The wound contaminants are most likely to originate from the environment and from the surrounding skin lesion, and to date, the most frequent bacteria isolated are

Identifiers

PMID34567124
PMCPMC8457973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.